Peptide Atlas · Peptide

Vesugen

The tripeptide Lys-Glu-Asp stimulated proliferation and inhibited apoptosis in organotypic cultures of neuroimmunoendocrine cells, with a stronger effect in cultures from old animals.

preclinical

provisional
PubChem 87571363
2 citations
0 discussions
0 followers
AC-2
KED peptide
Lysylglutamyl aspartic acid

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Vesugen. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
Effect of Lys-Glu-Asp on neuroimmunoendocrine cells in culture	preclinical	pmid 22977872
Review: peptide regulation of senescence in cardiovascular cells	preclinical	pmid 36611900

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.